Parkinson's Progression Markers Initiative
GPTKB entity
Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Research_Institute
|
| gptkbp:addressed |
health disparities
|
| gptkbp:aims_to |
identify biomarkers
|
| gptkbp:aims_to_improve |
clinical trials
patient care |
| gptkbp:analysis |
longitudinal studies
|
| gptkbp:collaborated_with |
government agencies
biotechnology firms |
| gptkbp:collaborates_with |
academic institutions
healthcare organizations |
| gptkbp:collaboration |
gptkb:scientists
|
| gptkbp:collection |
biological samples
clinical symptoms |
| gptkbp:conducts_research_on |
disease progression
|
| gptkbp:constructed_in |
research capacity
|
| gptkbp:contributes_to |
understanding of Parkinson's disease
|
| gptkbp:created |
data repositories
|
| gptkbp:development |
new assessment tools
|
| gptkbp:engages_in |
stakeholders
community outreach |
| gptkbp:evaluates |
cognitive decline
|
| gptkbp:explores |
environmental factors
|
| gptkbp:facilitates |
knowledge exchange
patient engagement |
| gptkbp:focuses_on |
gptkb:neurodegenerative_diseases
|
| gptkbp:fosters |
international collaborations
innovation in research |
| gptkbp:founded_in |
gptkb:2010
|
| gptkbp:has_participants |
healthy controls
patients with Parkinson's disease |
| https://www.w3.org/2000/01/rdf-schema#label |
Parkinson's Progression Markers Initiative
|
| gptkbp:investigates |
neuroprotective strategies
|
| gptkbp:is_a_resource_for |
gptkb:researchers
|
| gptkbp:is_analyzed_in |
non-motor symptoms
|
| gptkbp:is_based_in |
gptkb:United_States
|
| gptkbp:is_encouraging |
multidisciplinary research
|
| gptkbp:is_engaged_in |
patient recruitment
|
| gptkbp:is_enhanced_by |
gptkb:guidelines
research funding opportunities research methodologies |
| gptkbp:is_evaluated_by |
treatment outcomes
|
| gptkbp:is_focused_on |
quality of life
early detection |
| gptkbp:is_funded_by |
pharmaceutical companies
|
| gptkbp:is_incorporated_in |
patient-reported outcomes
|
| gptkbp:is_involved_in |
public awareness campaigns
|
| gptkbp:is_led_by |
scientific experts
|
| gptkbp:is_part_of |
larger research networks
|
| gptkbp:is_sought_after_by |
diagnosis of Parkinson's disease
treatment strategies |
| gptkbp:is_studied_for |
motor symptoms
|
| gptkbp:is_supported_by |
non-profit organizations
|
| gptkbp:notable_contributor |
gptkb:literature
policy development |
| gptkbp:originated_in |
therapeutic approaches
|
| gptkbp:promotes |
patient safety
evidence-based practices research transparency |
| gptkbp:publication |
biomarkers for Parkinson's disease
|
| gptkbp:support |
gptkb:healthcare_professionals
|
| gptkbp:track |
symptom progression
|
| gptkbp:utilizes |
clinical data
machine learning techniques genetic analysis data sharing platforms advanced imaging techniques |
| gptkbp:bfsParent |
gptkb:Michael_J._Fox_Foundation_for_Parkinson's_Research
|
| gptkbp:bfsLayer |
5
|